December 12, 2019
Asahi Kasei Pharma launched a subcutaneous autoinjector version of its osteoporosis drug Teribone (teriparatide acetate) on December 11. The new formulation joined the NHI price list on November 27, offering a new option in addition to the drug’s conventional vial...read more